Invention Grant
- Patent Title: Modified apidaecin derivatives as antibiotic peptides
-
Application No.: US15389802Application Date: 2016-12-23
-
Publication No.: US10435437B2Publication Date: 2019-10-08
- Inventor: Ralf Hoffmann , Daniel Knappe , Kai Hilpert , Ralf Mikut , Serge Ruden
- Applicant: UNIVERSITAET LEIPZIG
- Applicant Address: DE Leipzig
- Assignee: UNIVERSITAET LEIPZIG
- Current Assignee: UNIVERSITAET LEIPZIG
- Current Assignee Address: DE Leipzig
- Priority: DE102011118026 20110922
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K14/435 ; A61K38/00 ; A61K38/10

Abstract:
This invention relates to modified antibiotic peptides, particularly for use in medicine. The invention further relates to composite and methods for destroying microorganisms, such as bacteria, viruses or fungi, and to methods for treating microbial infections. The object of the invention is to develop novel antibiotic peptides, particularly having enhanced antibiotic activity and an expanded spectrum of activity against other strains of bacteria, particularly gram-positive bacteria such as Staphylococcus aureus. According to the invention, the object is attained in a first aspect by a peptide according to claim 1.
Public/Granted literature
- US20170107256A1 Modified Apidaecin Derivatives as Antibiotic Peptides Public/Granted day:2017-04-20
Information query